SPIN2 inhibitors are a class of compounds that target the epigenetic mechanisms controlling the expression and activity of SPIN2, a protein encoded by the SPIN2 gene. These inhibitors work by altering the chromatin state, thereby influencing the transcriptional regulation of SPIN2. Histone deacetylase (HDAC) inhibitors such as trichostatin A and vorinostat are known to modify the acetylation status of histones, leading to a more relaxed chromatin configuration that can change gene expression patterns, including those of SPIN2. Similarly, benzamide-derived HDAC inhibitors, cyclic peptides, and other HDAC inhibiting molecules exert their effects on the epigenetic landscape, potentially decreasing the functional activity of SPIN2 through modifications in gene transcription.
Another approach to inhibiting SPIN2 function involves the use of DNA methyltransferase inhibitors, which can affect gene expression by altering the methylation pattern of DNA. Compounds like 5-azacytidine and decitabine are examples of such inhibitors that can lead to hypomethylation of genomic DNA, potentially resulting in altered expression of SPIN2. These chemical agents, by intervening in the normal epigenetic regulation, may indirectly lead to the decreased functional activity of SPIN2.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
This compound is a histone deacetylase inhibitor that alters chromatin structure and gene expression, potentially impacting the regulatory mechanisms that control the expression of SPIN2. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that changes the methylation status of DNA, possibly affecting the expression regulation of SPIN2 by epigenetic modulation. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
A benzamide histone deacetylase inhibitor that can influence the acetylation status of histones, thereby possibly altering the transcriptional regulation of the SPIN2 gene. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
A non-nucleoside DNA methyltransferase inhibitor that might change the methylation pattern of the SPIN2 gene, potentially affecting its expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
An HDAC inhibitor that may alter the epigenetic regulation of the SPIN2 gene, potentially impacting its transcriptional activation or repression. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
A compound that inhibits class I and IV histone deacetylases, potentially affecting the chromatin state and thereby the expression of SPIN2. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
This inhibitor of DNA methyltransferase could alter the methylation status of genomic DNA, potentially affecting the expression of SPIN2. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
A cyclic peptide that inhibits HDAC, potentially impacting the transcription of SPIN2 by altering chromatin structure. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
A potent HDAC inhibitor that may impact the acetylation level of histones and thus could affect the transcriptional regulation of SPIN2. | ||||||
Chidamide | 743420-02-2 | sc-364462 sc-364462A sc-364462B | 1 mg 5 mg 25 mg | $62.00 $250.00 $1196.00 | ||
An HDAC inhibitor that might modulate the epigenetic state of the chromatin associated with SPIN2, potentially influencing its expression. | ||||||